RHINATHIOL ADULTS SYRUP 5%

Product Information

Registration Status: Active

RHINATHIOL ADULTS SYRUP 5% is approved to be sold in Singapore with effective from 1989-09-05. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN02759P.

This product contains Carbocisteine 5g/100ml in the form of SYRUP. It is approved for ORAL use.

This product is manufactured by Unither Liquid Manufacturing in FRANCE.

It is an Over-the-counter Medicine that can be freely obtained from any retailer

Carbocisteine

Description

Carbocisteine is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Carbocisteine is produced by alkylation of cysteine with chloroacetic acid.

Indication

Used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis.

Active Ingredient/Synonyms

(L)-2-Amino-3-(carboxymethylthio)propionic acid | (R)-S-(carboxymethyl)cysteine | L-3-((carboxymethyl)thio)alanine | L-carbocysteine | S-(carboxymethyl)-(R)-cysteine | S-carboxymethyl-L-cysteine | S-carboxymethylcysteine | Carbocisteine |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank